Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity?
- 31 August 2002
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 43 (2) , 119-130
- https://doi.org/10.1016/s0028-3908(02)00080-1
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemiaBrain Research, 2001
- Exacerbation of Neuronal Cell Death by Activation of Group I Metabotropic Glutamate Receptors: Role of NMDA Receptors and Arachidonic Acid ReleaseExperimental Neurology, 2001
- Selective Blockade of Type-1 Metabotropic Glutamate Receptors Induces Neuroprotection by Enhancing Gabaergic TransmissionMolecular and Cellular Neuroscience, 2001
- Activation of group I metabotropic glutamate receptors reduces neuronal apoptosis but increases necrotic cell death in vitroCell Death & Differentiation, 2000
- Role of Group I Metabotropic Glutamate Receptors in Traumatic Spinal Cord White Matter InjuryJournal of Neurotrauma, 1998
- Differential expression of rat and human type 1 metabotropic glutamate receptor splice variant messenger RNAsNeuroscience, 1998
- Prostaglandins stimulate calcium-dependent glutamate release in astrocytesNature, 1998
- The metabotropic glutamate receptor (mGluRlα) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reactionNeuron, 1993
- Quisqualate Metabotropic Receptors Modulate NMDA Currents and Facilitate Induction of Long‐Term Potentiation Through Protein Kinase CEuropean Journal of Neuroscience, 1992
- Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluRl, in transfected CHO cellsNeuron, 1992